«
»

Opportunities for Pharma in narcolepsy – The Pharma Letter (subscription)

Published February 22, 2012 | By admin
Opportunities for Pharma in narcolepsy
The Pharma Letter (subscription)
As a histamine (H3) receptor inverse agonist, the molecule has the potential to compete with current marketed products Provigil (modafinil), Nuvigil (armodafinil) – both from Cephalon, which has been acquired by Israel's Teva Pharmaceutical Industries ...

modafinil - Google News

Posted in Health | Tagged , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Modafinil 200mg caps x 100 Brand name: Provigil $119.95

Modafinil 200mg caps x 200 Brand name: Provigil $179.95

Modafinil 100mg caps x 100 Brand name: Modalert (Provigil) $86.18

Modafinil 100mg caps x 200 Brand name: Modalert (Provigil) $150.30

Categories

Copyright © 2012. All Rights Reserved.